M.D., Ph.D.

M.D., Ph.D.

Chief Medical OfficeratArcutis Biotherapeutics· In proxies 2022–2024

Pay in FY2024+51% from the year before · Arcutis Biotherapeutics stock +331.3% the same year

M.D., Ph.D. was paid $2.5M in FY2024 (Dec), up 51%. Arcutis Biotherapeutics stock rose 331.3% that year.

Pay$100 in the stock at the end of FY21 → $67
Pay is from the Summary Compensation Table of each Arcutis Biotherapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arcutis BiotherapeuticsPublic company · 4 yr
    • Chief Medical Officer2022 – Present · 4 yrStock in role +56%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?